A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Exact Sciences Corp stock. As of the latest transaction made, Ark Investment Management LLC holds 227,444 shares of EXAS stock, worth $13.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
227,444
Previous 344,487 33.98%
Holding current value
$13.2 Million
Previous $14.6 Million 6.4%
% of portfolio
0.15%
Previous 0.13%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$42.43 - $70.83 $4.97 Million - $8.29 Million
-117,043 Reduced 33.98%
227,444 $15.5 Million
Q2 2024

Jul 26, 2024

SELL
$41.33 - $74.26 $121 Million - $217 Million
-2,923,161 Reduced 89.46%
344,487 $14.6 Million
Q1 2024

Apr 18, 2024

SELL
$56.27 - $73.77 $156 Million - $204 Million
-2,765,245 Reduced 45.84%
3,267,648 $226 Million
Q4 2023

Jan 17, 2024

SELL
$59.06 - $75.72 $14.6 Million - $18.8 Million
-248,038 Reduced 3.95%
6,032,893 $446 Million
Q3 2023

Oct 18, 2023

SELL
$65.94 - $99.04 $57.6 Million - $86.6 Million
-874,167 Reduced 12.22%
6,280,931 $428 Million
Q2 2023

Jul 10, 2023

SELL
$62.68 - $95.05 $265 Million - $401 Million
-4,224,089 Reduced 37.12%
7,155,098 $672 Million
Q1 2023

Apr 17, 2023

SELL
$47.19 - $70.77 $220 Million - $330 Million
-4,661,303 Reduced 29.06%
11,379,187 $772 Million
Q4 2022

Jan 24, 2023

SELL
$30.35 - $53.15 $46.2 Million - $80.9 Million
-1,521,212 Reduced 8.66%
16,040,490 $0
Q3 2022

Oct 17, 2022

BUY
$31.97 - $49.37 $82.8 Million - $128 Million
2,589,937 Added 17.3%
17,561,702 $571 Million
Q2 2022

Jul 11, 2022

BUY
$35.61 - $76.23 $23.1 Million - $49.4 Million
647,803 Added 4.52%
14,971,765 $746 Million
Q1 2022

Apr 19, 2022

BUY
$57.56 - $82.54 $47.7 Million - $68.3 Million
827,948 Added 6.13%
14,323,962 $1 Billion
Q4 2021

Jan 28, 2022

BUY
$72.5 - $100.68 $128 Million - $178 Million
1,767,385 Added 15.07%
13,496,014 $1.05 Billion
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $90.4 Million - $124 Million
1,001,839 Added 9.34%
11,728,629 $1.12 Billion
Q2 2021

Aug 05, 2021

BUY
$93.66 - $139.27 $148 Million - $220 Million
1,578,155 Added 17.25%
10,726,790 $1.33 Billion
Q1 2021

May 13, 2021

BUY
$116.57 - $155.01 $447 Million - $595 Million
3,836,169 Added 72.21%
9,148,635 $1.21 Billion
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $476 Million - $680 Million
4,783,270 Added 903.87%
5,312,466 $704 Million
Q3 2020

Oct 30, 2020

BUY
$72.92 - $102.01 $38.6 Million - $54 Million
529,196 New
529,196 $54 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.